These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38284690)

  • 41. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.
    Huang H; Taylor DC; Carson RT; Sarocco P; Friedman M; Munsell M; Blum SI; Menzin J
    J Med Econ; 2015 Apr; 18(4):283-94. PubMed ID: 25333331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Home-based guided hypnotherapy for children with functional abdominal pain and irritable bowel syndrome in primary care: study protocol for a randomised controlled trial.
    Ganzevoort IN; Fokkema T; Mol-Alma HJ; Heida A; Van der Veen AL; Vermeulen K; Benninga MA; Vlieger AM; Berger MY; Holtman GA
    BMJ Open; 2023 May; 13(5):e069653. PubMed ID: 37156587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcutaneous Electrical Acustimulation Improved the Quality of Life in Patients With Diarrhea-Irritable Bowel Syndrome.
    Hu P; Sun K; Li H; Qi X; Gong J; Zhang Y; Xu L; Lin M; Fan Y; Chen JDZ
    Neuromodulation; 2022 Dec; 25(8):1165-1172. PubMed ID: 35088760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of sacral nerve stimulation as treatment for severe irritable bowel syndrome.
    Tipsmark LS; Fassov J; Lundby L; Laurberg S; Ehlers L; Krogh K
    Colorectal Dis; 2016 Jan; 18(1):O30-6. PubMed ID: 26466156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic burden of irritable bowel syndrome in China.
    Zhang F; Xiang W; Li CY; Li SC
    World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
    Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
    Mack I; Schwille-Kiuntke J; Mazurak N; Niesler B; Zimmermann K; Mönnikes H; Enck P
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1039-1047.e9. PubMed ID: 34214682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.
    Kemppinen A; Howell C; Allgar V; Dodd M; Gregson J; Knowles C; McLaughlin J; Pandya P; Whorwell P; Markaryan E; Yiannakou Y
    Trials; 2020 Jan; 21(1):122. PubMed ID: 32000822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome With Constipation by Accelerating Colon Transit and Reducing Rectal Sensation Using Autonomic Mechanisms.
    Huang Z; Lin Z; Lin C; Chu H; Zheng X; Chen B; Du L; Chen JDZ; Dai N
    Am J Gastroenterol; 2022 Sep; 117(9):1491-1501. PubMed ID: 35973183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Shah ED; Chang L; Salwen-Deremer JK; Gibson PR; Keefer L; Muir JG; Eswaran S; Chey WD
    Am J Gastroenterol; 2021 Apr; 116(4):748-757. PubMed ID: 33982945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic burden of inadequate symptom control among US commercially insured patients with irritable bowel syndrome with diarrhea.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Med Econ; 2017 Apr; 20(4):353-362. PubMed ID: 27919177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost Effectiveness of Biomarker Tests for Irritable Bowel Syndrome With Diarrhea: A Framework for Payers.
    Almario CV; Noah BD; Jusufagic A; Lew D; Spiegel BMR
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1434-1441.e21. PubMed ID: 29596984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous electrical nerve field stimulation improves comorbidities in children with cyclic vomiting syndrome.
    Karrento K; Zhang L; Conley W; Qazi Z; Venkatesan T; Simpson P; Li BUK
    Front Pain Res (Lausanne); 2023; 4():1203541. PubMed ID: 37389229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind randomised controlled trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in the treatment of faecal incontinence: CONtrol of Faecal Incontinence using Distal NeuromodulaTion (the CONFIDeNT trial).
    Horrocks EJ; Bremner SA; Stevens N; Norton C; Gilbert D; O'Connell PR; Eldridge S; Knowles CH
    Health Technol Assess; 2015 Sep; 19(77):1-164. PubMed ID: 26422980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-year follow-up of sacral nerve stimulation for patients with diarrhoea-predominant and mixed irritable bowel syndrome.
    Fassov J; Lundby L; Laurberg S; Buntzen S; Krogh K
    Colorectal Dis; 2017 Feb; 19(2):188-193. PubMed ID: 27328645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.